Grand Pharmaceutical Group Ltd
HKEX:512
Intrinsic Value
The intrinsic value of one Grand Pharmaceutical Group Ltd stock under the Base Case scenario is 3.95 HKD. Compared to the current market price of 5.6 HKD, Grand Pharmaceutical Group Ltd is Overvalued by 30%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Grand Pharmaceutical Group Ltd
Fundamental Analysis

Revenue & Expenses Breakdown
Grand Pharmaceutical Group Ltd
Balance Sheet Decomposition
Grand Pharmaceutical Group Ltd
Current Assets | 8B |
Cash & Short-Term Investments | 2.8B |
Receivables | 3.3B |
Other Current Assets | 2B |
Non-Current Assets | 17B |
Long-Term Investments | 8.2B |
PP&E | 4.3B |
Intangibles | 3.4B |
Other Non-Current Assets | 1.1B |
Free Cash Flow Analysis
Grand Pharmaceutical Group Ltd
HKD | |
Free Cash Flow | HKD |
Earnings Waterfall
Grand Pharmaceutical Group Ltd
Revenue
|
11.6B
HKD
|
Cost of Revenue
|
-4.9B
HKD
|
Gross Profit
|
6.7B
HKD
|
Operating Expenses
|
-4.5B
HKD
|
Operating Income
|
2.2B
HKD
|
Other Expenses
|
248.9m
HKD
|
Net Income
|
2.5B
HKD
|
Profitability Score
Profitability Due Diligence
Grand Pharmaceutical Group Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
Score
Grand Pharmaceutical Group Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Grand Pharmaceutical Group Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Score
Grand Pharmaceutical Group Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Grand Pharmaceutical Group Ltd
According to Wall Street analysts, the average 1-year price target for Grand Pharmaceutical Group Ltd is 6.83 HKD with a low forecast of 6.26 HKD and a high forecast of 7.56 HKD.
Dividends
Current shareholder yield for Grand Pharmaceutical Group Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one Grand Pharmaceutical Group Ltd stock under the Base Case scenario is 3.95 HKD.
Compared to the current market price of 5.6 HKD, Grand Pharmaceutical Group Ltd is Overvalued by 30%.